• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在雪貂模型中,奥司他韦敏感和耐药的高致病性 H5N1 流感病毒的竞争适应性。

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.

机构信息

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.

出版信息

J Virol. 2010 Aug;84(16):8042-50. doi: 10.1128/JVI.00689-10. Epub 2010 Jun 2.

DOI:10.1128/JVI.00689-10
PMID:20519385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2916532/
Abstract

The fitness of oseltamivir-resistant highly pathogenic H5N1 influenza viruses has important clinical implications. We generated recombinant human A/Vietnam/1203/04 (VN; clade 1) and A/Turkey/15/06 (TK; clade 2.2) influenza viruses containing the H274Y neuraminidase (NA) mutation, which confers resistance to NA inhibitors, and compared the fitness levels of the wild-type (WT) and resistant virus pairs in ferrets. The VN-H274Y and VN-WT viruses replicated to similar titers in the upper respiratory tract (URT) and caused comparable disease signs, and none of the animals survived. On days 1 to 3 postinoculation, disease signs caused by oseltamivir-resistant TK-H274Y virus were milder than those caused by TK-WT virus, and all animals survived. We then studied fitness by using a novel approach. We coinoculated ferrets with different ratios of oseltamivir-resistant and -sensitive H5N1 viruses and measured the proportion of clones in day-6 nasal washes that contained the H274Y NA mutation. Although the proportion of VN-H274Y clones increased consistently, that of TK-H274Y virus decreased. Mutations within NA catalytic (R292K) and framework (E119A/K, I222L, H274L, and N294S) sites or near the NA enzyme active site (V116I, I117T/V, Q136H, K150N, and A250T) emerged spontaneously (without drug pressure) in both pairs of viruses. The NA substitutions I254V and E276A could exert a compensatory effect on the fitness of VN-H274Y and TK-H274Y viruses. NA enzymatic function was reduced in both drug-resistant H5N1 viruses. These results show that the H274Y NA mutation affects the fitness of two H5N1 influenza viruses differently. Our novel method of assessing viral fitness accounts for both virus-host interactions and virus-virus interactions within the host.

摘要

对具有抗奥司他韦高致病性 H5N1 流感病毒的适应性具有重要的临床意义。我们生成了含有神经氨酸酶(NA)突变 H274Y 的重组人 A/Vietnam/1203/04(VN;1 类)和 A/Turkey/15/06(TK;2.2 类)流感病毒,该突变赋予了对 NA 抑制剂的抗性,并在雪貂中比较了野生型(WT)和耐药病毒对的适应性水平。VN-H274Y 和 VN-WT 病毒在上呼吸道(URT)中复制到相似的滴度,并引起相当的疾病症状,并且没有动物存活。在接种后 1 至 3 天,耐奥司他韦的 TK-H274Y 病毒引起的疾病症状比 TK-WT 病毒引起的疾病症状轻,所有动物均存活。然后,我们使用一种新方法研究了适应性。我们用不同比例的耐奥司他韦和敏感的 H5N1 病毒共同接种雪貂,并测量第 6 天鼻冲洗液中含有 H274Y NA 突变的克隆比例。尽管 VN-H274Y 克隆的比例持续增加,但 TK-H274Y 病毒的比例却下降了。NA 催化(R292K)和框架(E119A/K、I222L、H274L 和 N294S)位点或 NA 酶活性位点附近(V116I、I117T/V、Q136H、K150N 和 A250T)的突变自发出现(没有药物压力)在两种病毒对中。NA 取代 I254V 和 E276A 可以对 VN-H274Y 和 TK-H274Y 病毒的适应性产生补偿作用。两种耐药性 H5N1 病毒的 NA 酶功能均降低。这些结果表明,H274Y NA 突变对两种 H5N1 流感病毒的适应性有不同的影响。我们评估病毒适应性的新方法既考虑了病毒-宿主相互作用,也考虑了宿主内病毒-病毒相互作用。

相似文献

1
Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.在雪貂模型中,奥司他韦敏感和耐药的高致病性 H5N1 流感病毒的竞争适应性。
J Virol. 2010 Aug;84(16):8042-50. doi: 10.1128/JVI.00689-10. Epub 2010 Jun 2.
2
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.神经氨酸酶抑制剂耐药突变对 clade 2.2 A/土耳其/15/06(H5N1)流感病毒在雪貂中的致病性的影响。
PLoS Pathog. 2010 May 27;6(5):e1000933. doi: 10.1371/journal.ppat.1000933.
3
Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.位置 294 的天冬酰胺到丝氨酸突变对高致病性 H5N1 流感 A 病毒致病性的影响。
J Virol. 2011 May;85(10):4667-72. doi: 10.1128/JVI.00047-11. Epub 2011 Mar 2.
4
Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.对可能对多种神经氨酸酶抑制剂具有耐药性的流感病毒 N1 株进行分析和鉴定。
J Virol. 2015 Jan;89(1):287-99. doi: 10.1128/JVI.02485-14. Epub 2014 Oct 15.
5
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.对神经氨酸酶抑制剂耐药的重组A/越南/1203/04(H5N1)流感病毒在体外和体内均保持其复制效率和致病性。
J Virol. 2007 Nov;81(22):12418-26. doi: 10.1128/JVI.01067-07. Epub 2007 Sep 12.
6
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.神经氨酸酶突变 H274Y 对奥司他韦耐药性对新旧人类甲型流感 A(H1N1)病毒复制能力和毒力的影响。
J Infect Dis. 2010 Mar;201(5):740-5. doi: 10.1086/650464.
7
Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.在雪貂体内具有E119A和H274Y神经氨酸酶抑制剂耐药相关替换的乙型流感病毒的竞争适应性
PLoS One. 2016 Jul 28;11(7):e0159847. doi: 10.1371/journal.pone.0159847. eCollection 2016.
8
Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.在人气道上皮细胞共感染模型中具有神经氨酸酶抑制剂抗性替代的乙型流感病毒的竞争适应性
J Virol. 2015 Apr;89(8):4575-87. doi: 10.1128/JVI.02473-14. Epub 2015 Feb 11.
9
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.使用雪貂模型评估 A(H5N1) 流感病毒中奥司他韦和扎那米韦耐药性的发展。
Antiviral Res. 2010 Sep;87(3):361-6. doi: 10.1016/j.antiviral.2010.06.009. Epub 2010 Jul 21.
10
Interactions of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.在雪貂模型中对奥司他韦敏感和耐药的高致病性H5N1流感病毒的相互作用
Influenza Other Respir Viruses. 2011 May;5(Suppl 1):90-3.

引用本文的文献

1
Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution.针对H5Nx禽流感病毒的疫苗接种与抗病毒治疗:病毒控制或进化的先兆
Vaccines (Basel). 2023 Oct 24;11(11):1628. doi: 10.3390/vaccines11111628.
2
Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant Variants.巴洛沙韦治疗延缓雪貂中乙型流感病毒的传播,并导致耐药变异株的有限产生。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0113721. doi: 10.1128/AAC.01137-21. Epub 2021 Aug 23.
3
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.流感聚合酶抑制剂耐药性:现状评估——国际抗病毒研究学会(isirv)抗病毒小组报告。
Antiviral Res. 2021 Oct;194:105158. doi: 10.1016/j.antiviral.2021.105158. Epub 2021 Aug 4.
4
Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.人畜共患流感与人类健康 - 第2部分:临床特征、诊断、治疗及预防策略
Curr Infect Dis Rep. 2018 Aug 1;20(10):38. doi: 10.1007/s11908-018-0643-8.
5
Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.流感病毒耐药性产生的模型构建:表面蛋白、免疫反应及抗病毒机制的作用
PLoS One. 2017 Jul 10;12(7):e0180582. doi: 10.1371/journal.pone.0180582. eCollection 2017.
6
Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.在雪貂体内具有E119A和H274Y神经氨酸酶抑制剂耐药相关替换的乙型流感病毒的竞争适应性
PLoS One. 2016 Jul 28;11(7):e0159847. doi: 10.1371/journal.pone.0159847. eCollection 2016.
7
Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.奥司他韦的药代动力学/药效学建模与模拟,以评估针对流感-肺炎球菌合并感染的治疗策略。
Front Cell Infect Microbiol. 2016 Jun 14;6:60. doi: 10.3389/fcimb.2016.00060. eCollection 2016.
8
Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice.奥司他韦与T-705联合用药可延长小鼠高致病性甲型流感病毒(H5N1)感染的治疗窗口期。
Sci Rep. 2016 May 25;6:26742. doi: 10.1038/srep26742.
9
Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase.分子模拟研究表明,关键突变可能会影响甲型H1N1流感病毒神经氨酸酶对配体的识别。
J Mol Model. 2015 Nov;21(11):292. doi: 10.1007/s00894-015-2835-6. Epub 2015 Oct 26.
10
Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.靶向神经氨酸酶的一组精氨酸残基以避免甲型H1N1流感病毒对奥司他韦产生耐药性:一项理论研究。
J Mol Model. 2015 Jan;21(1):8. doi: 10.1007/s00894-014-2525-9. Epub 2015 Jan 22.

本文引用的文献

1
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.焦磷酸测序法检测 2009 年大流行流感 A(H1N1)病毒的耐药分子标志物。
Antimicrob Agents Chemother. 2010 Mar;54(3):1102-10. doi: 10.1128/AAC.01417-09. Epub 2009 Dec 22.
2
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.具有新型神经氨酸酶突变的扎那米韦耐药流感病毒。
J Virol. 2009 Oct;83(20):10366-73. doi: 10.1128/JVI.01200-09. Epub 2009 Jul 29.
3
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.大洋洲、东南亚和南非地区对奥司他韦耐药的甲型H1N1流感病毒的出现与传播
Antiviral Res. 2009 Jul;83(1):90-3. doi: 10.1016/j.antiviral.2009.03.003. Epub 2009 Mar 24.
4
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.美国出现对奥司他韦耐药的甲型H1N1流感病毒感染情况。
JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.
5
Developing new antiviral agents for influenza treatment: what does the future hold?开发用于流感治疗的新型抗病毒药物:未来会怎样?
Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. doi: 10.1086/591851.
6
Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.奥司他韦-利巴韦林联合疗法治疗小鼠高致病性H5N1流感病毒感染
Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97. doi: 10.1128/AAC.01579-07. Epub 2008 Aug 25.
7
Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.对奥司他韦耐药的甲型流感病毒可通过直接接触在豚鼠之间有效传播,但不能通过气溶胶传播。
J Virol. 2008 Oct;82(20):10052-8. doi: 10.1128/JVI.01226-08. Epub 2008 Aug 6.
8
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.季节性H1N1流感病毒神经氨酸酶的酶学特性为对奥司他韦产生天然抗性的出现提供了见解。
PLoS Pathog. 2008 Jul 25;4(7):e1000103. doi: 10.1371/journal.ppat.1000103.
9
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.耐奥司他韦流感病毒神经氨酸酶突变体的晶体结构
Nature. 2008 Jun 26;453(7199):1258-61. doi: 10.1038/nature06956. Epub 2008 May 14.
10
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.欧洲甲型H1N1流感病毒对奥司他韦耐药性的出现。
Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.